From the Food and Drug Administration |

Microwave Therapy Warning

Jane E. Henney, MD
JAMA. 2000;284(21):2711. doi:10.1001/jama.284.21.2711.
Text Size: A A A
Published online


The FDA warns physicians that treatment of benign prostatic hyperplasia (BPH) with microwave energy has been associated with serious thermal injuries and related complications. Ten of the 16 injuries reported in the last 4 years resulted in fistula formation and six in clinically significant tissue damage to the penis and urethra. The injuries have required colostomies, partial amputation of the penis, and other therapeutic interventions.

The agency has identified the following factors that may have contributed to the reported injuries: incorrect placement or undetected migration of the treatment catheter or the rectal temperature sensors; failure of the physician to remain with the patient throughout the treatment; failure to pause treatment when the patient is communicating serious pain; oversedation of the patient that compromised his ability to communicate pain; treatment of patients who have undergone prior radiation therapy to the pelvic area; treatment of patients whose prostate sizes are outside the ranges specified in the labeling; and water or air leakage from the balloons that retain the urethral catheter and the rectal temperature sensor, respectively, in the correct anatomical position.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Topics
PubMed Articles